Evidence map›Paper›PMID 41171629›Full record

ArticleeLife2025

Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2.

Siyu Chen, Tamar Basiashvili, Joshua Hutchings, Marta Sanz Murillo, Amalia Villagran Suarez, Erica Xiong, Jaime Alegrio Louro, Andres E Leschziner, Elizabeth Villa

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. LRRK2: Molecular Mechanisms in Parkinson's Disease.International journal of molecular sciences · 2026
    Review
  2. Article
  3. The molecular architecture of tunneling nanotubes.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Siyu ChenDepartment of Molecular Biology, University of California, San Diego, San Diego, United States.ORCID https://orcid.org/0000-0003-4565-4772
Tamar BasiashviliDepartment of Molecular Biology, University of California, San Diego, San Diego, United States.ORCID https://orcid.org/0000-0003-0394-3832
Joshua HutchingsDepartment of Molecular Biology, University of California, San Diego, San Diego, United States.ORCID https://orcid.org/0000-0001-6841-8583
Marta Sanz MurilloAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, United States.ORCID https://orcid.org/0000-0002-6175-9315
Amalia Villagran SuarezAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, United States.ORCID https://orcid.org/0000-0003-3400-2330
Erica XiongAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, United States.ORCID https://orcid.org/0009-0000-8023-5720
Jaime Alegrio LouroAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, United States.ORCID https://orcid.org/0000-0002-2800-923X
Andres E LeschzinerDepartment of Molecular Biology, University of California, San Diego, San Diego, United States.ORCID https://orcid.org/0000-0002-7732-7023
Elizabeth VillaDepartment of Molecular Biology, University of California, San Diego, San Diego, United States.ORCID https://orcid.org/0000-0003-4677-9809

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Aligning Science Across Parkinson's ASAP-000519European Molecular Biology Organization ALTF 871-2020National Science Foundation DBI 1920374NIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder. Mutations in human leucine-rich repeat kinase 2 (LRRK2), a multi-domain protein containing both a kinase and a GTPase, are a leading cause of the familial form of PD. Pathogenic LRRK2 mutations increase LRRK2 kinase activity. While the bulk of LRRK2 is found in the cytosol, the protein associates with membranes where its Rab GTPase substrates are found, and under certain conditions, with microtubules. Integrative structural studies using single-particle cryo-electron microscopy and in situ cryo-electron tomography (cryo-ET) have revealed the architecture of microtubule-associated LRRK2 filaments, and that formation of these filaments requires LRRK2's kinase to be in the active-like conformation. However, whether LRRK2 can interact with and form filaments on microtubules in its autoinhibited state, where the kinase domain is in the inactive conformation and the N-terminal LRR domain covers the kinase active site, was not known. Using cryo-ET, we show that full-length human LRRK2 can oligomerize on microtubules in its autoinhibited state. Both WT-LRRK2 and PD-linked LRRK2 mutants formed filaments on microtubules. While these filaments are stabilized by the same interfaces seen in the active-LRRK2 filaments, we observed a new interface involving the N-terminal repeats that were disordered in the active-LRRK2 filaments. The helical parameters of the autoinhibited-LRRK2 filaments are different from those reported for the active-LRRK2 filaments. Finally, the autoinhibited-LRRK2 filaments are shorter and less regular, suggesting they are less stable.

Indexed as

Electron Microscope TomographyLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MicrotubulesCryoelectron MicroscopyHumansProtein BindingProtein MultimerizationLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanhumanLRRK2microtubulesmolecular biophysicsneuroscienceparkinson's diseasestructural biology

Identifiers

PMID41171629
PMCPMC12578439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.